Concepts (217)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tuberculosis, Multidrug-Resistant | 13 | 2023 | 930 | 1.020 |
Why?
|
| Antitubercular Agents | 15 | 2018 | 1373 | 0.930 |
Why?
|
| Latent Tuberculosis | 1 | 2021 | 224 | 0.620 |
Why?
|
| Mycobacterium tuberculosis | 10 | 2018 | 1903 | 0.550 |
Why?
|
| Clonorchis sinensis | 1 | 2010 | 3 | 0.380 |
Why?
|
| Tuberculosis, Pulmonary | 5 | 2021 | 831 | 0.340 |
Why?
|
| Heart Aneurysm | 1 | 2010 | 114 | 0.340 |
Why?
|
| Tuberculosis | 5 | 2023 | 2001 | 0.330 |
Why?
|
| Infarction | 1 | 2010 | 247 | 0.310 |
Why?
|
| Chagas Disease | 1 | 2010 | 167 | 0.300 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2010 | 373 | 0.290 |
Why?
|
| Ascariasis | 1 | 2006 | 13 | 0.270 |
Why?
|
| Ascaris lumbricoides | 1 | 2006 | 10 | 0.270 |
Why?
|
| HIV Infections | 9 | 2024 | 17275 | 0.260 |
Why?
|
| Cholangitis | 1 | 2006 | 113 | 0.240 |
Why?
|
| Bile Ducts | 1 | 2006 | 282 | 0.240 |
Why?
|
| Acquired Immunodeficiency Syndrome | 4 | 2023 | 2197 | 0.240 |
Why?
|
| Liver | 2 | 2010 | 7502 | 0.210 |
Why?
|
| Tissue and Organ Procurement | 1 | 2010 | 943 | 0.200 |
Why?
|
| Anthozoa | 1 | 2021 | 65 | 0.190 |
Why?
|
| Tuberculosis, Spinal | 2 | 2017 | 16 | 0.180 |
Why?
|
| Lung Diseases, Parasitic | 1 | 2019 | 14 | 0.170 |
Why?
|
| Awards and Prizes | 1 | 2023 | 359 | 0.160 |
Why?
|
| Liver Transplantation | 1 | 2010 | 2325 | 0.160 |
Why?
|
| Pulmonary Eosinophilia | 1 | 2019 | 78 | 0.160 |
Why?
|
| Tuberculosis, Male Genital | 1 | 2018 | 6 | 0.160 |
Why?
|
| Orchitis | 1 | 2018 | 35 | 0.150 |
Why?
|
| Epididymitis | 1 | 2018 | 37 | 0.150 |
Why?
|
| Immunomodulation | 1 | 2021 | 545 | 0.140 |
Why?
|
| Tuberculosis, Osteoarticular | 1 | 2017 | 26 | 0.140 |
Why?
|
| Tuberculosis, Urogenital | 1 | 2016 | 9 | 0.140 |
Why?
|
| AIDS-Related Opportunistic Infections | 3 | 2010 | 662 | 0.140 |
Why?
|
| Edema | 2 | 2018 | 768 | 0.130 |
Why?
|
| Sputum | 3 | 2014 | 502 | 0.120 |
Why?
|
| Directly Observed Therapy | 3 | 2012 | 139 | 0.120 |
Why?
|
| Testis | 1 | 2018 | 794 | 0.120 |
Why?
|
| Joint Diseases | 1 | 1998 | 457 | 0.120 |
Why?
|
| Kidney | 1 | 2010 | 7016 | 0.120 |
Why?
|
| Diagnosis, Differential | 8 | 2019 | 12951 | 0.120 |
Why?
|
| Hepatitis C | 1 | 2024 | 1579 | 0.110 |
Why?
|
| South Africa | 4 | 2014 | 1821 | 0.110 |
Why?
|
| Endometrium | 1 | 2016 | 403 | 0.110 |
Why?
|
| Endemic Diseases | 1 | 2014 | 190 | 0.100 |
Why?
|
| Abdominal Pain | 2 | 2010 | 1063 | 0.100 |
Why?
|
| Clonorchiasis | 1 | 2010 | 5 | 0.090 |
Why?
|
| Meningitis, Viral | 1 | 2011 | 50 | 0.090 |
Why?
|
| Musculoskeletal Diseases | 1 | 2017 | 595 | 0.090 |
Why?
|
| Antiparasitic Agents | 1 | 2010 | 43 | 0.090 |
Why?
|
| Infertility, Female | 1 | 2016 | 759 | 0.090 |
Why?
|
| Nifurtimox | 1 | 2010 | 14 | 0.090 |
Why?
|
| Laboratories, Hospital | 1 | 2011 | 192 | 0.090 |
Why?
|
| Peru | 5 | 2012 | 884 | 0.090 |
Why?
|
| Flank Pain | 1 | 2010 | 43 | 0.090 |
Why?
|
| Trypanocidal Agents | 1 | 2010 | 41 | 0.090 |
Why?
|
| Knee Joint | 1 | 1998 | 1664 | 0.080 |
Why?
|
| Pregnancy Complications, Infectious | 3 | 2009 | 2125 | 0.080 |
Why?
|
| Chagas Cardiomyopathy | 1 | 2010 | 71 | 0.080 |
Why?
|
| Humans | 39 | 2024 | 758381 | 0.080 |
Why?
|
| Mass Screening | 2 | 2024 | 5425 | 0.080 |
Why?
|
| Tuberculosis, Cutaneous | 1 | 2008 | 17 | 0.080 |
Why?
|
| Tuberculosis, Central Nervous System | 1 | 2008 | 16 | 0.080 |
Why?
|
| Internal Medicine | 2 | 2024 | 1048 | 0.070 |
Why?
|
| Extensively Drug-Resistant Tuberculosis | 1 | 2008 | 85 | 0.070 |
Why?
|
| Models, Organizational | 1 | 2011 | 546 | 0.070 |
Why?
|
| National Health Programs | 1 | 2011 | 439 | 0.070 |
Why?
|
| Herpes Simplex | 1 | 2011 | 478 | 0.070 |
Why?
|
| Sarcoma | 1 | 1998 | 1785 | 0.070 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2011 | 586 | 0.070 |
Why?
|
| Radiography, Abdominal | 1 | 2010 | 532 | 0.070 |
Why?
|
| Hepatic Duct, Common | 1 | 2006 | 48 | 0.070 |
Why?
|
| Program Evaluation | 2 | 2011 | 2490 | 0.070 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2011 | 748 | 0.070 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2011 | 556 | 0.060 |
Why?
|
| Cholecystitis | 1 | 2006 | 181 | 0.060 |
Why?
|
| Refusal to Participate | 1 | 2024 | 31 | 0.060 |
Why?
|
| Cholelithiasis | 1 | 2006 | 407 | 0.060 |
Why?
|
| South Carolina | 1 | 2024 | 100 | 0.060 |
Why?
|
| Liver Function Tests | 1 | 2006 | 523 | 0.060 |
Why?
|
| Health Services Accessibility | 2 | 2012 | 5403 | 0.060 |
Why?
|
| Medically Underserved Area | 1 | 2006 | 257 | 0.060 |
Why?
|
| Health Services Needs and Demand | 1 | 2011 | 1401 | 0.050 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2006 | 506 | 0.050 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2011 | 932 | 0.050 |
Why?
|
| Adult | 17 | 2024 | 219916 | 0.050 |
Why?
|
| Cholestasis | 1 | 2006 | 377 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3076 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3196 | 0.050 |
Why?
|
| Hepatectomy | 1 | 2006 | 559 | 0.050 |
Why?
|
| Treatment Outcome | 8 | 2018 | 64379 | 0.050 |
Why?
|
| Lung | 2 | 2019 | 9985 | 0.050 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2004 | 255 | 0.050 |
Why?
|
| Drug Resistance, Multiple | 1 | 2003 | 253 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2014 | 3812 | 0.050 |
Why?
|
| Ultrasonography | 2 | 2018 | 5952 | 0.050 |
Why?
|
| Risk Factors | 3 | 2021 | 73806 | 0.050 |
Why?
|
| Sarcoma, Kaposi | 1 | 2004 | 374 | 0.050 |
Why?
|
| Rifampin | 1 | 2023 | 339 | 0.050 |
Why?
|
| Cough | 2 | 2019 | 594 | 0.050 |
Why?
|
| Animals | 6 | 2021 | 167777 | 0.050 |
Why?
|
| Anti-Retroviral Agents | 1 | 2010 | 1780 | 0.050 |
Why?
|
| HIV | 1 | 2007 | 1581 | 0.040 |
Why?
|
| Delivery of Health Care | 2 | 2023 | 5331 | 0.040 |
Why?
|
| Dengue | 1 | 2003 | 254 | 0.040 |
Why?
|
| Immune Reconstitution Inflammatory Syndrome | 2 | 2010 | 61 | 0.040 |
Why?
|
| Brain Diseases | 1 | 2008 | 1541 | 0.040 |
Why?
|
| Elephantiasis, Filarial | 1 | 2019 | 31 | 0.040 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2021 | 328 | 0.040 |
Why?
|
| Health Policy | 1 | 2011 | 2675 | 0.040 |
Why?
|
| Cardiomyopathy, Hypertrophic, Familial | 1 | 2019 | 63 | 0.040 |
Why?
|
| Developing Countries | 1 | 2011 | 2866 | 0.040 |
Why?
|
| Drug Monitoring | 2 | 2017 | 960 | 0.040 |
Why?
|
| Female | 19 | 2024 | 390316 | 0.040 |
Why?
|
| Male | 15 | 2024 | 358742 | 0.040 |
Why?
|
| Lung Diseases, Fungal | 1 | 2019 | 126 | 0.040 |
Why?
|
| Anti-HIV Agents | 3 | 2012 | 4504 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2010 | 36285 | 0.040 |
Why?
|
| Crohn Disease | 1 | 2011 | 2275 | 0.040 |
Why?
|
| Testicular Diseases | 1 | 2018 | 73 | 0.040 |
Why?
|
| Poverty | 2 | 2008 | 2692 | 0.040 |
Why?
|
| Decision Making | 1 | 2011 | 3915 | 0.040 |
Why?
|
| Hepatitis C, Chronic | 1 | 2006 | 1031 | 0.040 |
Why?
|
| Graft Rejection | 1 | 2010 | 4426 | 0.040 |
Why?
|
| Hemofiltration | 1 | 2017 | 59 | 0.040 |
Why?
|
| Hysterosalpingography | 1 | 2016 | 26 | 0.040 |
Why?
|
| Tenosynovitis | 1 | 2017 | 57 | 0.030 |
Why?
|
| CD4 Lymphocyte Count | 2 | 2014 | 2569 | 0.030 |
Why?
|
| Fallopian Tubes | 1 | 2016 | 178 | 0.030 |
Why?
|
| Educational Status | 1 | 2023 | 2513 | 0.030 |
Why?
|
| Orchiectomy | 1 | 2018 | 470 | 0.030 |
Why?
|
| Nepal | 1 | 2016 | 301 | 0.030 |
Why?
|
| Fever | 1 | 2003 | 1617 | 0.030 |
Why?
|
| Synovial Membrane | 1 | 1998 | 524 | 0.030 |
Why?
|
| Proportional Hazards Models | 3 | 2015 | 12440 | 0.030 |
Why?
|
| Counseling | 1 | 2023 | 1541 | 0.030 |
Why?
|
| Internship and Residency | 2 | 2024 | 5865 | 0.030 |
Why?
|
| Schools | 1 | 2023 | 1482 | 0.030 |
Why?
|
| Eosinophilia | 1 | 2019 | 559 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2010 | 7985 | 0.030 |
Why?
|
| Public Health | 1 | 2007 | 2658 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2011 | 7377 | 0.030 |
Why?
|
| Granuloma | 1 | 2016 | 327 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2011 | 9160 | 0.030 |
Why?
|
| Middle Aged | 7 | 2024 | 219560 | 0.030 |
Why?
|
| Ethiopia | 1 | 2015 | 462 | 0.030 |
Why?
|
| Arthritis, Infectious | 1 | 2017 | 345 | 0.030 |
Why?
|
| Back Pain | 1 | 2017 | 543 | 0.030 |
Why?
|
| Delayed Diagnosis | 1 | 2017 | 463 | 0.030 |
Why?
|
| Arthritis | 1 | 1998 | 666 | 0.030 |
Why?
|
| Osteomyelitis | 1 | 2017 | 407 | 0.030 |
Why?
|
| Time Factors | 5 | 2014 | 39873 | 0.030 |
Why?
|
| Radiography, Thoracic | 1 | 2019 | 1296 | 0.030 |
Why?
|
| Georgia (Republic) | 1 | 2011 | 39 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2010 | 7403 | 0.020 |
Why?
|
| Young Adult | 5 | 2024 | 58808 | 0.020 |
Why?
|
| Retrospective Studies | 6 | 2024 | 80170 | 0.020 |
Why?
|
| Lesotho | 1 | 2011 | 74 | 0.020 |
Why?
|
| Antiretroviral Therapy, Highly Active | 2 | 2012 | 1895 | 0.020 |
Why?
|
| Integrin alpha4 | 1 | 2011 | 87 | 0.020 |
Why?
|
| Therapeutic Equipoise | 1 | 2010 | 28 | 0.020 |
Why?
|
| Cost of Illness | 1 | 2020 | 1936 | 0.020 |
Why?
|
| Russia | 1 | 2011 | 381 | 0.020 |
Why?
|
| Pregnancy | 4 | 2023 | 29742 | 0.020 |
Why?
|
| Herpesvirus 3, Human | 1 | 2011 | 158 | 0.020 |
Why?
|
| Herpesvirus 2, Human | 1 | 2011 | 191 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2010 | 20500 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2021 | 9650 | 0.020 |
Why?
|
| Organizational Objectives | 1 | 2011 | 426 | 0.020 |
Why?
|
| Financing, Personal | 1 | 2011 | 309 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2014 | 1436 | 0.020 |
Why?
|
| Fertilization in Vitro | 1 | 2016 | 1292 | 0.020 |
Why?
|
| Renal Dialysis | 1 | 2017 | 1786 | 0.020 |
Why?
|
| Massachusetts | 1 | 2020 | 8823 | 0.020 |
Why?
|
| HIV Seronegativity | 1 | 2008 | 211 | 0.020 |
Why?
|
| Child | 2 | 2012 | 79813 | 0.020 |
Why?
|
| Community Health Services | 1 | 2011 | 655 | 0.020 |
Why?
|
| Public Sector | 1 | 2007 | 265 | 0.020 |
Why?
|
| Urban Health | 1 | 2008 | 533 | 0.020 |
Why?
|
| Comorbidity | 1 | 2020 | 10495 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2019 | 6363 | 0.020 |
Why?
|
| Vulnerable Populations | 1 | 2011 | 699 | 0.020 |
Why?
|
| Point-of-Care Systems | 1 | 2014 | 1201 | 0.020 |
Why?
|
| Program Development | 1 | 2011 | 1297 | 0.020 |
Why?
|
| Health Plan Implementation | 1 | 2007 | 336 | 0.010 |
Why?
|
| Critical Illness | 1 | 2017 | 2703 | 0.010 |
Why?
|
| Biopsy | 1 | 2016 | 6768 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2009 | 1829 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2013 | 6233 | 0.010 |
Why?
|
| Cooperative Behavior | 1 | 2011 | 1501 | 0.010 |
Why?
|
| Medication Adherence | 1 | 2015 | 2155 | 0.010 |
Why?
|
| Sri Lanka | 1 | 2003 | 92 | 0.010 |
Why?
|
| Lymphocytes | 1 | 2011 | 2610 | 0.010 |
Why?
|
| Models, Educational | 1 | 2006 | 373 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2010 | 4839 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2012 | 6353 | 0.010 |
Why?
|
| Dyspnea | 1 | 2009 | 1344 | 0.010 |
Why?
|
| Population Surveillance | 1 | 2011 | 2606 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8611 | 0.010 |
Why?
|
| Adolescent | 2 | 2024 | 87888 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2011 | 5490 | 0.010 |
Why?
|
| Patient Care Team | 1 | 2011 | 2504 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2004 | 13245 | 0.010 |
Why?
|
| Aged | 2 | 2024 | 168217 | 0.010 |
Why?
|
| Social Support | 1 | 2008 | 2153 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2008 | 6293 | 0.010 |
Why?
|
| Radiography | 1 | 2009 | 6955 | 0.010 |
Why?
|
| Health Care Costs | 1 | 2011 | 3245 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2020 | 41252 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 15225 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 2008 | 2768 | 0.010 |
Why?
|
| Travel | 1 | 2003 | 785 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2003 | 1945 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2008 | 8530 | 0.010 |
Why?
|
| Healthcare Disparities | 1 | 2011 | 3362 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 58681 | 0.010 |
Why?
|
| Curriculum | 1 | 2006 | 3717 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2009 | 26182 | 0.000 |
Why?
|
| United States | 1 | 2006 | 72140 | 0.000 |
Why?
|
Concepts
(217)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(94)
People in Profiles who have published with this person.
Explore
_
Similar People
(59)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_